Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07211542
PHASE2

A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd

View on ClinicalTrials.gov

Summary

This trial was designed to evaluate the efficacy and safety of SHR-1905 in patients with moderate-to-severe atopic dermatitis.

Official title: A Randomized, Double-blind, Placebo-controlled Phase IIa Study to Evaluate the Efficacy and Safety of SHR-1905 Injection in Patients With Moderate to Severe Atopic Dermatitis

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

75

Start Date

2025-11-07

Completion Date

2027-02

Last Updated

2026-04-08

Healthy Volunteers

No

Interventions

DRUG

SHR-1905 Injection

SHR-1905 injection.

DRUG

SHR-1905 Injection Blank Preparation

SHR-1905 injection blank preparation.

Locations (1)

Dermatology Hospital of Southern Medical University

Guangzhou, Guangdong, China